Save time and get answers to complex questions with AI chat
How to apply for vascepa's patient assistance?Atorvastatin side effects heart palpitations?Somatuline generic name?Patent tenofovir alafenamide gilead?Patent expiration date of guselkumab?
See the DrugPatentWatch profile for xarelto
Xarelto's Patent Protection and Exclusivity Contribute to High Prices Xarelto's (rivaroxaban) high cost is a result of its patent protection and exclusivity in the market. According to [1] DrugPatentWatch.com, Johnson & Johnson, the pharmaceutical company behind Xarelto, has received multiple patents for the drug, which extends its exclusive marketing rights until 2029. How Long Will Exclusivity Last? The patent expires in various markets at different times. For example, the patent for Xarelto in the United States expires in 2029 for certain indications, while it expires in 2031 for others [2]. As long as the patent is in effect, Xarelto's exclusivity will contribute to its high price, restricting competition and limiting options for generic or biosimilar alternatives. Competition from Biosimilars The entrance of biosimilars can significantly impact a drug's price. However, the development of Xarelto biosimilars has been delayed due to the complexities of creating a drug of this nature. Companies such as Mylan have attempted to develop a biosimilar but have faced setbacks [3]. The development of biosimilars for Xarelto is still in its early stages, and it remains unclear when these alternatives will be available. Regulatory Environment and Pricing Pressures Governments and regulatory bodies have increased scrutiny on high-priced medicines, including Xarelto. For example, the European Commission has implemented policies to improve transparency and fairness in pharmaceutical pricing, potentially affecting Xarelto's price [4]. However, it is uncertain whether these efforts will lead to significant changes. What Patients Can Do Patients struggling with the cost of Xarelto can explore options such as medication assistance programs or coupons. Pharmaceutical companies may offer discounts or rebates for patients with financial need. Additionally, the price of Xarelto can vary significantly depending on the country and region, so patients may be able to find more affordable options by crossing borders. Sources: [1] DrugPatentWatch.com [2] US Patent and Trademark Office [3] Mylan Investor Relations [4] European Commission - Pharmaceutical sector
Other Questions About Xarelto :